Regulatory Momentum

• 105 dossiers filed across Europe, Asia, Latin America, Middle East & Africa
  
• 285 product approvals received globally
  

Intellectual Property Expansion

• Three design patents filed for RESET packaging
  
• Renal Guard platform patent granted in South Africa
  

These filings extended protection beyond molecules to packaging innovation and platform technologies.

Technology Front

We are pioneers in Indian pharmaceuticals, achieving milestones like DSIR accreditation and CPCSEA approval.

Our groundbreaking Human Organ-on-a-Chip lab and advanced speciality labs drive industry standards.

We set ambitious tech goals, ensuring quality through GXP standards and fostering collaborations for medical advancements.

‍

• Collaborated with the best clinical research organisation in India – Veeda Clinical Research, to conduct the unique clinical trials of our pipeline molecule – VRP-034.
• We also collaborated with Nortis Bio, U.S., to upgrade our organ-on-a-chip lab with dual-channel chips.

Scientific Participation

• VRP-034 study accepted and presented at a leading European microbiology conference
  
• Participation at ECCMID strengthened infectious disease engagement
  

Consumer Healthcare Expansion

• Launch of RESET Ultra Potent Gel
  
• Launch of Herbal Detox Candies
  
• First design patents filed for packaging research in herbal segment
  

FY24 reflected diversified growth — combining global regulatory strength, intellectual protection, scientific visibility, and consumer healthcare expansion.